1 year return (CAGR)
6525.21%
Active Biotech AB Exchange (ST, SEK)
ACTI.ST
4.00
+0.17 (+4.44%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
158.79%
5 year return (CAGR)
58.56%
10 year return (CAGR)
7.14%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
105.31M
Price/Sales
-
Ent value
72.11M
Price/Book
2.83
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-16.59%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.81 |
| Daily high | 4.17 |
| Daily low | 3.81 |
| Daily Volume | 40K |
| All-time high | 103.64 |
| 1y analyst estimate | 25.00 |
| Beta | 1.39 |
| EPS (TTM) | -1.27 |
| Dividend per share | 0.00 |
| Ex-div date | 17 Apr 1998 |
| Next earnings date | 7 May 2026 |
Downside potential
Loading...
Downside potential data
| ACTI.ST | S&P500 | |
| Current price drop from All-time high | -96.15% | -3.00% |
| Highest price drop | -99.96% | -56.47% |
| Date of highest drop | 18 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -92.40% | -10.65% |
| Avg time to new high | 3734 days | 12 days |
| Max time to new high | 7467 days | 1805 days |
News
The Q3 earnings cycle continues to roll along, with several healthcare companies delivering positive results and raising their outlooks as a result.
November 2, 2026
Jungfraubahn Holding has delivered a 105.3% share price gain over the past 5 years, which naturally puts the spotlight on whether the current Swiss franc price is adequately backed by the cash the bus...
November 2, 2026
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that Novartis Pharma AG has notified BioArctic that it has decided to terminate the Option, Collaboration and License Agreement entered i...
November 2, 2026
PARIS, November 02, 2026--Regulatory News: Gecina (Paris:GFC):
November 2, 2026
Press release - Regulated Information Melexis: update on the share buy-back program Ieper, Belgium – 2 November 2026, 17.45 hrs CET Melexis reports the purchase of 9,800 Melexis shares on Euronext Bru...
November 2, 2026
Investing.com -- Deutsche Bank downgraded pharmaceutical company Novartis to “sell” from “hold” and cut its price target to CHF115 from CHF120, saying the shares have more than recovered losses from t...
November 2, 2026
Novartis (SWX:NOVN) reported new trial data showing Votrient plus Roche's Avastin improved overall survival in certain advanced kidney cancer patients. The combination delivered overall survival outco...
November 2, 2026
St. Galler Kantonalbank has quietly produced a strong share price story over the past few years, which naturally raises a question for anyone looking at the stock today. Are investors paying a price t...
November 1, 2026
Oil has quietly moved back to the center of the story, with Brent forecasts being revised higher and geopolitical risk now baked into every barrel. That ripple effect touches funding costs, inflation ...
October 31, 2026